VERA Q3 2022 Earnings — Vera Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

VERAVera Therapeutics, Inc.

$3B

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$25M

Net Income

-$25M

EPS (Diluted)

$-0.89

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$18M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$131M

Total Liabilities

$26M

Stockholders' Equity

$106M

Cash & Equivalents

$30M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$25M	-$7M	-248.1%
Net Income	-$25M	-$8M	-224.3%